Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 4
2010 3
2011 4
2012 4
2013 4
2014 9
2015 1
2016 7
2017 6
2018 4
2019 4
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.
Lalatsa A, Statts L, Adriana de Jesus J, Adewusi O, Auxiliadora Dea-Ayuela M, Bolas-Fernandez F, Dalastra Laurenti M, Felipe Domingues Passero L, Serrano DR. Lalatsa A, et al. Among authors: dalastra laurenti m. Int J Pharm. 2020 Oct 15;588:119734. doi: 10.1016/j.ijpharm.2020.119734. Epub 2020 Aug 7. Int J Pharm. 2020. PMID: 32777535
Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis.
Bezerra-Souza A, Fernandez-Garcia R, Rodrigues GF, Bolas-Fernandez F, Dalastra Laurenti M, Passero LF, Lalatsa A, Serrano DR. Bezerra-Souza A, et al. Among authors: dalastra laurenti m. Pharmaceutics. 2019 Jul 20;11(7):353. doi: 10.3390/pharmaceutics11070353. Pharmaceutics. 2019. PMID: 31330776 Free PMC article.
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.
Fernández-García R, Statts L, de Jesus JA, Dea-Ayuela MA, Bautista L, Simão R, Bolás-Fernández F, Ballesteros MP, Laurenti MD, Passero LFD, Lalatsa A, Serrano DR. Fernández-García R, et al. Among authors: laurenti md. ACS Infect Dis. 2020 Oct 9;6(10):2647-2660. doi: 10.1021/acsinfecdis.0c00293. Epub 2020 Sep 2. ACS Infect Dis. 2020. PMID: 32810398
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page